Graphite Bio Inc
NASDAQ:LENZ

Watchlist Manager
Graphite Bio Inc Logo
Graphite Bio Inc
NASDAQ:LENZ
Watchlist
Price: 16.85 USD 2.25% Market Closed
Market Cap: 527.2m USD

Net Margin
Graphite Bio Inc

-336.5%
Current
-106%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-336.5%
=
Net Income
-58.9m
/
Revenue
17.5m

Net Margin Across Competitors

No Stocks Found

Graphite Bio Inc
Glance View

Market Cap
480.2m USD
Industry
Biotechnology

Graphite Bio, Inc. operates as a clinical-stage gene editing company. The company is headquartered in South San Francisco, California and currently employs 120 full-time employees. The company went IPO on 2021-06-25. The firm has a gene editing platform that is designed to correct mutations, replace entire disease-causing genes with normal genes, or insert new genes into predetermined, safe locations. Its research program, GPH102 for the treatment of beta-thalassemia, leverages its gene replacement platform technology by replacing one or both copies of the mutated beta-globin (HBB) gene through HDR to restore HgbA expression to levels. GPH201 is an investigational treatment for X-linked severe combined immunodeficiency syndrome (XSCID), a rare, life-threatening disease where multiple mutations in a single gene (IL2RG) prevent normal immune system function. GPH301 is for the treatment of Gaucher disease. Its pipeline program also includes therapeutic protein production and non-genotoxic conditioning (NGTC).

LENZ Intrinsic Value
33.19 USD
Undervaluation 49%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-336.5%
=
Net Income
-58.9m
/
Revenue
17.5m
What is the Net Margin of Graphite Bio Inc?

Based on Graphite Bio Inc's most recent financial statements, the company has Net Margin of -336.5%.

Back to Top